We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sun Pharma might soon be able to free itself of whistleblower allegations weighing on its shares—at least from the securities watchdog’s point of view.
The UK’s Medicines and Healthcare products Regulatory Agency is considering whether to allow over-the-counter sales of erectile dysfunction drug sildenafil, which was originally on the...